READCOOR
ReadCoor is a technology company offering the first true spatial multi-omic platform to the global audience of researchers, clinicians, pharma and diagnostics companies to expand understanding of human biology and to facilitate the creation of new therapeutics for patients. The company’s RC2 Platform simultaneously detects and reads the sequences of tens to thousands of RNA, DNA, proteins, and therapeutics and visualizes sub-cellular nanoscale 3D resolution in every cell throughout any tissue section. The Platform, based on ReadCoor’s proprietary Fluorescent in situ Sequencing (FISSEQ) technology, combines the massive multiplexity of next-generation sequencing (NGS) and high-resolution tissue imaging.
READCOOR
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2016-09-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.readcoor.com
Total Employee:
11+
Status:
Closed
Contact:
(617)453-2660
Email Addresses:
[email protected]
Total Funding:
52.5 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail IPv6 Google Apps For Business Cloudflare Hosting COVID-19 Cloudflare DNS MailChimp SPF
Current Advisors List
Current Employees Featured
Founder
Investors List
Decheng Capital
Decheng Capital investment in Series B - ReadCoor
Pavilion Capital
Pavilion Capital investment in Series B - ReadCoor
Hansjörg Wyss
Hansjörg Wyss investment in Series B - ReadCoor
Silicon Valley Community Foundation
Silicon Valley Community Foundation investment in Grant - ReadCoor
Chan Zuckerberg Initiative
Chan Zuckerberg Initiative investment in Grant - ReadCoor
Hansjörg Wyss
Hansjörg Wyss investment in Series A - ReadCoor
Lilly Asia Ventures
Lilly Asia Ventures investment in Series A - ReadCoor
Decheng Capital
Decheng Capital investment in Series A - ReadCoor
Vivo Capital
Vivo Capital investment in Series A - ReadCoor
Official Site Inspections
http://www.readcoor.com
- Host name: 172.67.160.100
- IP address: 172.67.160.100
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "ReadCoor" on Search Engine
ReadCoor - Crunchbase Company Profile & Funding
ReadCoor is a technology company offering the first true spatial multi-omic platform to the global audience of researchers, clinicians, pharma and diagnostics companies to …See details»
ReadCoor Company Profile 2024: Valuation, Investors, …
Read Coor, Inc. Ownership Status. Acquired/Merged. Financing Status. Formerly VC-backed. Primary Industry. Discovery Tools (Healthcare) Other Industries. Biotechnology. …See details»
ReadCoor Inc. | Devex
Learn more about ReadCoor Inc.'s jobs, projects, latest news, contact information and geographical presence. ReadCoor is commercializing a new generation sequencing …See details»
ReadCoor Company Profile - Craft
ReadCoor’s is a company developing a spatial sequencing platform, Fluorescent in situ Sequencing (FISSEQ), that produces readouts and 3D images for disease diagnosis. …See details»
Method of the Year: spatially resolved transcriptomics - Nature
Jan 19, 2021 ReadCoor brought scientists, a “foundational technology,” intellectual property and technology development, since the team that built the company’s …See details»
Wyss Institute launches ReadCoor to commercialize 3D
Sep 28, 2016 (BOSTON) — The Wyss Institute for Biologically Inspired Engineering at Harvard University today announced that its FISSEQ (fluorescent in situ sequencing) technology will be commercialized by a …See details»
Exclusive: How Sequencing Firm ReadCoor Came to be …
Oct 11, 2020 In an exclusive interview, the company told ChinaBio® Today about ReadCoor's revolutionary technology and its significance for functional genomics, drug …See details»
ReadCoor, Inc. Unveils True Spatial Sequencing Platform to Drive ...
Feb 24, 2020 ReadCoor is a technology company offering the first true spatial multi-omic platform to the global audience of researchers, clinicians, pharma and diagnostics …See details»
10x Genomics Signs Agreement to Acquire ReadCoor
Oct 7, 2020 Read time: 2 minutes. Continuing on its mission of mastering biology to advance human health, 10x Genomics, Inc. (Nasdaq: TXG) today announced that it has entered into a definitive agreement to acquire …See details»
Why 10X Genomics (TXG) Acquired ReadCoor And …
Oct 7, 2020 10X Genomics Inc (NASDAQ: TXG) recently announced it entered into a definitive agreement to buy ReadCoor (developer of foundational In Situ technologies) for cash and stock consideration of …See details»
ReadCoor Receives Grant from Chan Zuckerberg Initiative
Jan 3, 2018 CAMBRIDGE, Mass.-- ( BUSINESS WIRE )--ReadCoor, Inc., a company reinventing omics and pathology with its panomic spatial sequencing platform, today …See details»
ReadCoor - Funding, Financials, Valuation & Investors
ReadCoor has raised a total of. $52.5M. in funding over 4 rounds. Their latest funding was raised on Jan 10, 2020 from a Series B round. ReadCoor is funded by 7 investors. …See details»
ReadCoor | VentureRadar
Founded in 2016. Private Company. Offers a panomic spatial sequencing platform utilizing Fluorescent in situ Sequencing (FISSEQ) for researchers, clinicians, and pharma …See details»
10x Genomics to Acquire ReadCoor for $350M, Cartana for $41.2M
Oct 5, 2020 Login Now. The deals give 10x Genomics control of a combined 110 patents covering in situ analysis methods that the firm says will complement its existing platforms.See details»
10X Genomics acquires ReadCoor - 2020-10-05 - Crunchbase
Oct 5, 2020 Overview. Acquired Organization: ReadCoor Leader in true multi-omic spatial sequencing. Acquiring Organization: 10X Genomics 10X Genomics ELV …See details»
ReadCoor, Inc. Unveils True Spatial Sequencing Platform to Drive ...
Feb 24, 2020 ReadCoor is a technology company offering the first true spatial multi-omic platform to the global audience of researchers, clinicians, pharma and diagnostics …See details»
ReadCoor will commercialize the Wyss Institute’s (FISSEQ
Sep 29, 2016 ReadCoor, Inc. ( http://readcoor.com) is leading the next generation of “omics” by delivering the first panomic spatial sequencing platform to the global …See details»
Analysis: 10x Genomics acquires ReadCoor for $350m
Oct 12, 2020 • Kaloyan Andonov, Rob Lavine. Eli Lilly is to exit the genetic sequencing system provider Readcoor in a cash-and-share acquisition by 10x Genomics. This is …See details»
ReadCoor Launched to Commercialize 3D Sequencing Tech
Sep 29, 2016 The Wyss Institute for Biologically Inspired Engineering at Harvard University announced that its FISSEQ (fluorescent in situ sequencing) technology will be …See details»
ReadCoor, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
May 1, 2024 Private Company |. 2016 |. Massachusetts, United States. |. 10-50. |. www.readcoor.com. Last update 01 May 2024. Overview. Pipeline. Deal. Translational …See details»